Portfolio category: Medtech

Deciphex is an Irish digital pathology company. It has developed AI / deep learning platforms focused on applications for clinical and veterinary pathology that improve productivity and help pathologists focus on the critical content.

Perfuze is based in Galway, Ireland. It develops innovative catheter technology to treat acute ischemic stroke, providing superior clinical outcomes in shorter procedural times. Perfuze has developed super-bore diameter aspiration technology that has the capability to navigate the complex neurovascular anatomy. Perfuze’ pipeline of products are designed to facilitate fast, complete clot removal during acute ischemic stroke.

Palliare is an Irish company which develops and manufactures an insufflation device for laparoscopic and endoscopic surgery with in-built smoke evacuation technology.

Atlantic Therapeutics is a spin-out from BMR (Galway). It developed a non-invasive neuromuscular electrical stimulation device to treat various forms of incontinence (stress-urinary, faecal, and mixed-urinary). Caldera Medical acquired the company’s assets in September 2023.

Endotronix, with a subsidiary in Ireland and headquartered in Illinois, USA, is developing a novel implantable pulmonary artery pressure monitor and integrated patient management platform to provide comprehensive management tools for heart failure patients.

Apica Cardiovascular was a developer of a platform access and closure device for the delivery of therapeutic medical devices through the apex of the heart. Apica was acquired by Thoratec in July 2014.

PQ Bypass is a medical device company working to transform the treatment of long-segment femoropopliteal disease with minimally-invasive endovascular solutions. The company was sold to Endologix in April 2021.

Quanta, both UK and US based, is developing advanced haemodialysis systems for dialysis patients which can be used in the home and in the clinic. Quanta technologies are simple and easy to use, accessible and empowering, liberating dialysis patients to live their lives.

Medlumics, based in Spain, is developing new medical devices for the treatment of Cardiac Rhythm Disturbances. It designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias.

Veryan developed innovative stent solutions to treat peripheral vascular disease. Veryan’s BioMimics 3D Vascular Stent System has a unique 3D helical geometry to improve treatment outcomes in peripheral vascular disease. The Product is FDA approved and marketed in the US.The company was acquired by Otsuka Medical in December 2018.

Novate developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism.The company was sold to BTG in September 2018.

Labcyte develops acoustic liquid handling products for applications in research and drug development.
Labcyte was acquired by Beckman Coulter in 2019.